Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus.
AUTOR(ES)
Leclercq, R
RESUMO
Staphylococcus haemolyticus BM4610 was resistant to high levels of lincomycin and susceptible to macrolides, clindamycin, and streptogramins. This resistance phenotype, not previously reported for a human clinical isolate, was due to inactivation of the antibiotic. The gene conferring resistance to lincomycin in strain BM4610 was carried by a 2.5-kilobase plasmid, pIP855, which was cloned in Escherichia coli. Plasmid pIP855 caused inactivation of both lincomycin and clindamycin in S. haemolyticus and in E. coli but conferred detectable resistance to lincomycin only in S. haemolyticus and to clindamycin only in E. coli.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=180265Documentos Relacionados
- Plasmid-Mediated Resistance to Gentamicin in Staphylococcus aureus
- Mechanism of Plasmid-Mediated Resistance to Cadmium in Staphylococcus aureus
- Plasmid-mediated resistance to phagocytosis in Yersinia enterocolitica.
- Plasmid-mediated resistance to antibiotic synergism in enterococci.
- Plasmid-mediated sulfonamide resistance in Neisseria meningitidis.
